Neurosciences articles for Switzerland

Time frame: 1 May 2025 - 30 April 2026

View topic

Count: 100

Article ‘Count’ for Neurosciences.

Journal Count Share
10 2.12
Cerebrospinal Fluid Amyloid‐β Biomarkers Predict Future Hemorrhage in Patients with Cerebral Amyloid Angiopathy 0.03
Stroke Etiologies With Intravenous Thrombolysis before Thrombectomy and Functional Outcomes in Anterior Circulation Large Vessel Occlusion 0.09
Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale 0.06
<atl>Effects of Intradural Extension of Extracranial Cervical Artery Dissection on Outcomes: A Secondary Analysis From the scpSTOP/scp ‐ scpCAD/scp Study</atl> 0.13
Thrombectomy versus Medical Management for Pediatric Acute Ischemic Stroke Due to Isolated M2 Occlusion: A Multicenter Cohort Study 0.19
Skeletal Muscle Biomarkers of Amyotrophic Lateral Sclerosis: A Large‐Scale, Multi‐Cohort Proteomic Study 0.41
Cuneiform Nucleus Stimulation Can Assist Gait Training to Promote Locomotor Recovery in Individuals With Incomplete Tetraplegia 1.00
Subthalamic Electrophysiological Mapping of Gait Initiation Dynamics and Freezing in Parkinson's Disease 0.04
The Role of Electroencephalography in Predicting Post-Stroke Seizures and an Updated Prognostic Model (SeLECT-EEG) 0.17
Deep Brain Stimulation for scpiVPS16/i/scp‐Related Dystonia: A Multicenter Study 0.01
1 0.09
B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment 0.09
1 0.11
Pharmacodynamic Effects of Litifilimab in Lupus in the LILAC Phase II Study: Rapid and Sustained Reductions in Type I Interferon‐Associated Gene Expression and Cytokines 0.11
7 1.81
Spatial propagation of movement-related basal ganglia activity predicts parkinsonian motor state 0.78
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study 0.04
Associations between epilepsy-related polygenic risk and brain morphology in childhood 0.03
Brain atrophy patterns in anti-IgLON5 disease 0.03
A digital motor score for sensitive detection of progression in Huntington’s disease 0.64
Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder 0.27
Neurotransmitter-informed connectivity maps and their application for outcome inference after stroke 0.03
4 1.41
Myelin antigen capture in the CNS by B cells expressing EBV latent membrane protein 1 leads to demyelinating lesion formation 0.89
A glycolytic shunt via the pentose phosphate pathway is a metabolic checkpoint for nervous system sensory homeostasis and axonal regeneration 0.05
Astrocytes functionally integrate multiple synapses via specialized leaflet domains 0.42
The immunoproteasome disturbs neuronal metabolism and drives neurodegeneration in multiple sclerosis 0.05
1 0.56
Structural insights into copper and zinc binding to tau protein and the impact of metal binding on amyloid aggregation 0.56
2 0.14
Herpes Simplex Virus Type 1 Encephalitis: A Prospective Population-Based Cohort Study 0.11
Non-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort 0.03
1 0.89
Sex Disparities in the Clinical Management and Outcomes of Critically Ill Adults Undergoing Electroencephalography Monitoring. 0.89
2 1.12
Sensory neurons shape local macrophage identity via TGF-β signaling 0.12
Interleukin-34-dependent perivascular macrophages promote vascular function in the brain 1.00
1 1.00
Current trends in stroke events, mortality, and case fatality in Switzerland: an epidemiologic update 1.00
1 0.02
Intracranial Pressure Treatment Thresholds in Pediatric Traumatic Brain Injury 0.02
1 0.01
Multivariate Brain-Blood Signatures in Early-Stage Depression and Psychosis 0.01
2 1.05
Levodopa Added to Stroke Rehabilitation 0.95
Frequency and Clinical Outcomes Associated With Tau Positron Emission Tomography Positivity 0.11
1 1.00
In situ metabolomics reveals intra-islet metabolite changes upon in vivo stimulation of insulin secretion 1.00
2 1.22
Dynamic alterations of dural and bone marrow B cells in an animal model of progressive multiple sclerosis 0.22
Oligodendrocyte-derived IL-33 regulates self-reactive CD8+ T cells in CNS autoimmunity 1.00
1 0.94
Stable Mechanoreceptive Somatotopy in Chronic Low Back Pain: Is Cortical Map Reorganization a Myth? 0.94
2 0.39
Lactate potentiates NMDA receptor currents via an intracellular redox mechanism targeting GluN2B subunits: implications for synaptic plasticity 0.14
The role of acid-base balance in cerebrovascular and ventilatory responses to CO2 during 10 h normobaric hypoxia 0.25
1 0.07
Femtosecond Soft X-ray Absorption Spectroscopy Identifies Metal-Centered S1 Excited State of Cyanocobalamin 0.07
3 2.03
Gesture deficits in psychosis and the combination of group psychotherapy and transcranial magnetic stimulation: A randomized clinical trial 0.90
Mapping symptom-general and symptom-specific targets for transcranial magnetic stimulation in schizophrenia: an electric-field modeling meta-analysis 1.00
CLN5 deficiency impairs glucose uptake and uncovers PHGDH as a potential biomarker in Batten disease 0.13
3 0.35
Astrocytes connect specific brain regions through plastic networks 0.08
Intestinal macrophages modulate synucleinopathy along the gut–brain axis 0.07
Synthetic α-synuclein fibrils replicate in mice causing MSA-like pathology 0.20
15 6.70
Neurons of the human subthalamic nucleus engage with local delta frequency processes during action cancellation 0.02
Distinct modes of dopamine modulation on striatopallidal synaptic transmission 0.13
Descending inhibitory rostral ventromedial medulla neurons cause widespread antinociception and contribute to the pain-inhibits-pain phenomenon 0.77
TNF alpha unmasks enteric malate aspartate shuttle dysfunction bridging Parkinson disease and intestinal inflammation 0.12
Alzheimer’s Aβ catalyzes Tau phase separation and aggregation via early nanocluster solubilization 0.75
Prime editing of the β adrenoceptor in the brain restores physiological REM sleep in a mouse model of Alzheimer’s disease 0.89
Personalized biomarkers of multiscale functional alterations in temporal lobe epilepsy 0.04
Age modulates the link between stress-related neural activity and mortality 0.92
Development of [F]ACI-19626 as a first-in-class brain PET tracer for imaging TDP-43 pathology 0.81
In vivo imaging of the barrier properties of the glia limitans during health and neuroinflammation 1.00
Synthetic chaperone based on Hsp90-Tau interaction inhibits Tau aggregation and rescues physiological Tau-Microtubule interaction 0.06
Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson’s disease 0.14
Synaptic loss pattern is constrained by brain connectome and modulated by phosphorylated tau in Alzheimer’s disease 0.13
Cell-specific mechanisms drive connectivity across the time course of Huntington’s disease 0.03
Astrocytic GLUT1 deletion in adult mice enhances glucose metabolism and resilience to stroke 0.89
2 0.04
Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis 0.01
Genetic modifiers of somatic expansion and clinical phenotypes in Huntington’s disease highlight shared and tissue-specific effects 0.03
1 0.09
A transcriptomic microglia taxonomy across mouse and human pathologies 0.09
7 0.98
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial 0.06
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disorders 0.02
High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial 0.05
Oral splicing modulator branaplam in Huntington’s disease: a phase 2 randomized controlled trial 0.38
Intrathecal onasemnogene abeparvovec in treatment-naive patients with spinal muscular atrophy: a phase 3, randomized controlled trial 0.04
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial 0.06
AI-driven reclassification of multiple sclerosis progression 0.39
4 0.31
Sleep-dependent infraslow rhythms are evolutionarily conserved across reptiles and mammals 0.10
Impaired capillary–venous drainage contributes to gliosis and demyelination in mouse white matter during aging 0.08
Tau PET positivity in individuals with and without cognitive impairment varies with age, amyloid-β status, genotype and sex 0.03
Response of spatially defined microglia states with distinct chromatin accessibility in a mouse model of Alzheimer’s disease 0.10
1 0.95
Neurons undergo IFNγ-driven persistent epigenetic shifts and synaptopathy in encephalitis 0.95
3 1.09
Large-scale seroepidemiology uncovers nephro-urological pathologies in people with tau autoimmunity 1.00
Sleep deprivation and sleep intensity exert distinct effects on cerebral vasomotion and brain pulsations driven by the respiratory and cardiac cycles 0.04
Combining gamma neuromodulation and robotic rehabilitation after a stroke restores parvalbumin interneuron dynamics and improves motor recovery in mice 0.05
1 0.94
Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial) 0.94
3 1.81
Preservation of anticorrelated brain networks predicts recovery after traumatic brain injury 0.10
Higher-order interactions in neuronal function: From genes to ionic currents in biophysical models 0.71
Cardiac signals inform auditory regularity processing in the absence of consciousness 1.00
1 0.04
Blocking RAN translation without altering repeat RNAs rescues C9ORF72-related ALS and FTD phenotypes 0.04
1 0.11
Structure of the Huntingtin F-actin complex reveals its role in cytoskeleton organization 0.11
5 1.54
Skin thermal dynamics and hypothalamic thermosensitivity dissociate REM sleep and cataplexy in narcolepsy 0.73
Brain-derived tau for monitoring brain injury in acute ischemic stroke 0.07
Reconnecting the vagus nerve to the heart through nerve conduit preserves cardiac function in a minipig model of right cardiac vagotomy 0.02
Immune signatures link myelin oligodendrocyte glycoprotein antibody–associated disease to other autoantibody-mediated conditions 0.66
SV2A-PET imaging uncovers cortical synapse loss in multiple sclerosis 0.07
2 0.13
Direct interaction between TDP-43 and Tau promotes their co-condensation, while suppressing Tau fibril formation and seeding 0.10
Tau uptake by human neurons depends on receptor LRP1 and kinase LRRK2 0.04
1 0.13
The burden of stroke, ischaemic heart disease, and dementia in Africa, 1990–2021: an ecological analysis of the Global Burden of Disease 2021 0.13
3 0.33
Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1 Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial 0.05
Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO2MSE): a prospective, multicentre case–control study 0.24
Association between the Edinburgh CT and genetic diagnostic criteria for cerebral amyloid angiopathy-associated lobar intracerebral haemorrhage and recurrent intracerebral haemorrhage: an individual patient data meta-analysis 0.05
3 0.29
Asundexian for Secondary Stroke Prevention 0.02
Risdiplam in Presymptomatic Spinal Muscular Atrophy 0.23
Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1 0.05

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.